BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18174726)

  • 1. Improving growth in children with inflammatory bowel disease.
    Ahmed SF; Wong JS; McGrogan P
    Horm Res; 2007; 68 Suppl 5():117-21. PubMed ID: 18174726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-promoting hormone therapy in inflammatory bowel disease.
    Savage MO
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51 Suppl 3():S135-6. PubMed ID: 21088536
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease.
    Ezri J; Marques-Vidal P; Nydegger A
    Digestion; 2012; 85(4):308-19. PubMed ID: 22688404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of pro-inflammatory cytokines in inflammatory bowel disease growth retardation.
    Wong SC; Macrae VE; McGrogan P; Ahmed SF
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):144-55. PubMed ID: 16877976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of treatment regimens and pubertal status for growth in IBD.
    DeBoer MD; Barnes BH
    J Pediatr; 2009 Jun; 154(6):936-7; author reply 937. PubMed ID: 19446107
    [No Abstract]   [Full Text] [Related]  

  • 6. The growth hormone insulin-like growth factor 1 axis in children and adolescents with inflammatory bowel disease and growth retardation.
    Wong SC; Smyth A; McNeill E; Galloway PJ; Hassan K; McGrogan P; Ahmed SF
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):220-8. PubMed ID: 20184596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and management of abnormal growth in children with chronic inflammatory bowel disease.
    Ahmed SF; Farquharson C; McGrogan P; Russell RK
    World Rev Nutr Diet; 2013; 106():142-8. PubMed ID: 23428693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutritional and metabolic issues in inflammatory bowel disease.
    Cabré E; Gassull MA
    Curr Opin Clin Nutr Metab Care; 2003 Sep; 6(5):569-76. PubMed ID: 12913675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory cytokines and growth in childhood.
    Marcovecchio ML; Mohn A; Chiarelli F
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):57-62. PubMed ID: 22157401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions.
    Wong SC; Dobie R; Altowati MA; Werther GA; Farquharson C; Ahmed SF
    Endocr Rev; 2016 Feb; 37(1):62-110. PubMed ID: 26720129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: The clinical importance of growth in children with inflammatory bowel disease: is it important to the gastroenterologist?
    Taminiau JA
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():53-6. PubMed ID: 18081649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases (review).
    MacRae VE; Wong SC; Farquharson C; Ahmed SF
    Int J Mol Med; 2006 Dec; 18(6):1011-8. PubMed ID: 17089003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional concerns in pediatric inflammatory bowel disease patients.
    Kappelman MD; Bousvaros A
    Mol Nutr Food Res; 2008 Aug; 52(8):867-74. PubMed ID: 18324705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth failure in the child with inflammatory bowel disease.
    Stephens M; Batres LA; Ng D; Baldassano R
    Semin Gastrointest Dis; 2001 Oct; 12(4):253-62. PubMed ID: 11726079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting growth in chronic inflammatory disease: lessons from studies of the growth plate.
    Ahmed SF; Sävendahl L
    Horm Res; 2009 Nov; 72 Suppl 1():42-7. PubMed ID: 19940495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth hormone therapy for children with chronic diseases].
    Barreto AM; Bigolin MC; Ramos JC; Machado LP; Silva Ldos R; Silveira RB; Boguszewski MC
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):774-82. PubMed ID: 18797584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently?
    Griffiths AM
    Dig Dis; 2009; 27(3):404-11. PubMed ID: 19786772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
    Bright GM; Mendoza JR; Rosenfeld RG
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of growth hormone and insulin-like growth factor-1 in Crohn's disease: implications for therapeutic use of human growth hormone in pediatric patients.
    Vortia E; Kay M; Wyllie R
    Curr Opin Pediatr; 2011 Oct; 23(5):545-51. PubMed ID: 21900782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of natural products actions on cytokines in inflammatory bowel disease.
    Hur SJ; Kang SH; Jung HS; Kim SC; Jeon HS; Kim IH; Lee JD
    Nutr Res; 2012 Nov; 32(11):801-16. PubMed ID: 23176791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.